Connection

JOSEPH JANKOVIC to Hyperkinesis

This is a "connection" page, showing publications JOSEPH JANKOVIC has written about Hyperkinesis.
Connection Strength

2.210
  1. Dopamine depleters in the treatment of hyperkinetic movement disorders. Expert Opin Pharmacother. 2016 Dec; 17(18):2461-2470.
    View in: PubMed
    Score: 0.518
  2. Tetrabenazine for the treatment of chorea and other hyperkinetic movement disorders. Expert Rev Neurother. 2011 Nov; 11(11):1509-23.
    View in: PubMed
    Score: 0.364
  3. Treatment of hyperkinetic movement disorders. Lancet Neurol. 2009 Sep; 8(9):844-56.
    View in: PubMed
    Score: 0.313
  4. Long-term tolerability of tetrabenazine in the treatment of hyperkinetic movement disorders. Mov Disord. 2007 Jan 15; 22(2):193-7.
    View in: PubMed
    Score: 0.261
  5. Tetrabenazine in the treatment of hyperkinetic movement disorders. Expert Rev Neurother. 2006 Jan; 6(1):7-17.
    View in: PubMed
    Score: 0.243
  6. Real-World Experiences with VMAT2 Inhibitors in Pediatric Hyperkinetic Movement Disorders. Tremor Other Hyperkinet Mov (N Y). 2025; 15:26.
    View in: PubMed
    Score: 0.234
  7. Analysis of CYP2D6 genotype and response to tetrabenazine. Mov Disord. 2013 Feb; 28(2):210-5.
    View in: PubMed
    Score: 0.099
  8. Chorea and ballism. Curr Opin Neurol Neurosurg. 1992 Jun; 5(3):308-13.
    View in: PubMed
    Score: 0.095
  9. Respiratory problems in neurologic movement disorders. Parkinsonism Relat Disord. 2010 Dec; 16(10):628-38.
    View in: PubMed
    Score: 0.083
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.